Disclosure 0001193125-26-384878-1

SEC FORM 4

$2,252.39

Ultragenyx Pharmaceutical Inc. (RARE)

Sale of 161 shares at $13.99 per share.

Reporting Person Huizenga Theodore Alan · Officer Title SVP, Chief Accounting Officer · Transaction Code S

Traded Sep 3, 2026 · Disclosed Sep 8, 2026

Source: SEC Form 4 · 0001193125-26-384878 · filed 2026-09-08 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Ultragenyx Pharmaceutical Inc. (RARE)." Disclosed 2026-09-08. https://desqlong.com/cards/0001193125-26-384878-1 (retrieved 2026-09-26).